Search Results 6931-6940 of 25555 for oral

  1. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

  2. Psoriasis - Doctors and departments - Mayo Clinic

    romelalgia, Rosacea, Oral lichen planus, Chronic hives, Contact dermatitis, Stevens-Johnson syndrome. Show more areas of focus for Mark Denis P. Davis, M.D. ...

  3. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women with Recurrent or Persistent Endometrial Cancer” - Mayo Clinic

    Patients must be able to swallow and retain oral medications and without gastrointestinal. Patients must have adequately controlled blood pressure (BP) ...

  4. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  5. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  6. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

    implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner 6. Signed and dated ...

  7. To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis - Mayo Clinic

    Inability to swallow food or any condition of the upper gastrointestinal tract that precludes administration of oral medications. Recent history of ...

  8. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

  9. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

  10. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...